Study of Obeldesivir in Children and Adolescents With COVID-19
Public ClinicalTrials.gov record NCT05996744. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2/3 Single-Arm, Open-label Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Obeldesivir in Pediatric Participants With COVID-19
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical study is to learn more about the safety and tolerability of obeldesivir (ODV) in children and adolescents with coronavirus disease 2019 (COVID-19). The primary objectives are to evaluate the plasma pharmacokinetics (PK), safety and tolerability of ODV in pediatric participants with COVID-19.
Study identification
- NCT ID
- NCT05996744
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 3 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Up to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 26, 2023 (Actual)
- Primary completion
- Feb 23, 2024 (Actual)
- Completion
- Feb 23, 2024 (Actual)
- Last update posted
- Feb 3, 2025
2023 – 2024
United States locations
- U.S. sites
- 18
- U.S. states
- 9
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Trinity Clinical Research, LLC | Centreville | Alabama | 35042 | — |
| Advanced Research Center, Inc. | Anaheim | California | 92805 | — |
| Stanford University Medical Center | Palo Alto | California | 94304 | — |
| UF Health- Shands Hospital | Gainesville | Florida | 32610 | — |
| Encore Medical Research LLC | Hollywood | Florida | 33021 | — |
| Accel Research Sites Network - Nona Pediatric Center | Orlando | Florida | 32829 | — |
| Avanza Medical Research Center | Pensacola | Florida | 32503 | — |
| Santos Research Center | Tampa | Florida | 33603 | — |
| Pas Research | Tampa | Florida | 33613 | — |
| Velocity Clinical Research, Norfolk | Norfolk | Nebraska | 68701 | — |
| Velocity Clinical Research, Omaha | Omaha | Nebraska | 68134 | — |
| Pas Research | Las Vegas | Nevada | 89128 | — |
| Velocity Clinical Research -Albuquerque | Albuquerque | New Mexico | 87107 | — |
| Child Health Care Associates | East Syracuse | New York | 13057 | — |
| Velocity Clinical Research, Charleston | Charleston | South Carolina | 29414 | — |
| PanAmerican Clinical Research, LLC | Brownsville | Texas | 78520 | — |
| Texas Children's Hospital | Houston | Texas | 77030 | — |
| The University of Texas Medical School at Houston | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05996744, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 3, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05996744 live on ClinicalTrials.gov.